TV 목록 보기
경제
지난 주요뉴스 한국경제TV에서 선정한 지난 주요뉴스 뉴스썸 한국경제TV 웹사이트에서 접속자들이 많이 본 뉴스 한국경제TV 기사만 onoff
[PRNewswire] 온코퀘스트(OncoQuest), 임상 2단계 관련 2개의 보고서 발간 2020-03-25 09:13:24
of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. For further information: Dr. Madi R. Madiyalakan, Chief Executive Officer, OncoQuest Inc., Tel: (780) 448-1400 Ext. 204, Email: madi@oncoquestinc.com; Hany S. Awadalla, Senior Vice President and Chief...
[ 분야별 송고기사 LIST ]-외신 2019-02-12 15:00:07
190212-0264 외신-005510:00 [PRNewswire] FDA Accepts sBLA and Grants Priority Review for BAVENCIO(R) 190212-0267 외신-005610:01 MSCI 중국지수에 샤오미·메이퇀·핀둬둬 등 편입 190212-0279 외신-005710:06 미국 교사 "임금인상" 파업 확산…덴버에서도 거리시위 190212-0300 외신-005810:17 INF조약 폐기 여파,...
[PRNewswire] FDA Accepts sBLA and Grants Priority Review for BAVENCIO(R) 2019-02-12 10:00:30
[PRNewswire] FDA Accepts sBLA and Grants Priority Review for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) for the Treatment of Advanced Renal Cell Carcinoma -- Not intended for US, Canada and UK-based media (DARMSTADT, Germany and NEW YORK, February 11, 2019 PRNewswire=연합뉴스) Merck and Pfizer...
[ 분야별 송고기사 LIST ]-외신 2017-03-01 15:00:05
10:50 [PRNewswire] FDA Accepts the Biologics License Application for Avelumab for 170301-0318 외신-0058 10:52 트럼프 "사소한 싸움 뒤로 하자" 의회연설서 통합 촉구 170301-0319 외신-0059 10:52 "항응고제-항혈소판제, 뇌출혈 위험↑" 170301-0324 외신-0060 10:58 中인민일보 자매지 "삼성·현대도 조만간 어려움...
[PRNewswire] FDA Accepts the Biologics License Application for Avelumab for 2017-03-01 10:50:55
[PRNewswire] FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review * Not intended for US and UK-based media -- Second Biologics License Application accepted by the FDA for avelumab -- Prognosis for urothelial carcinoma...
TV 목록 보기
경제
